+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-28Number of Pages: 60

Prefilled Syringe Small Molecule Market (Therapeutic Class - Neurology Drug, Cardiovascular Drugs, Analgesics, and Adjuvants) - U.S. and EU-5 Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

1 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Introduction
    1.1 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Report Description
    1.2 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Research Methodology 
    1.3 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Market Segmentation 
    1.4 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Assumptions & Acronyms

2 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Executive Summary
    2.1 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Executive Summary 

3 U.S. & EU5 Prefilled Syringes Small Molecules Market Overview
    3.1 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Key Market Insights
    3.2 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Market Dynamics 
    3.3 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Porter’s Five Force Analysis    
    3.4 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Trends
    3.5 U.S. & EU5 Prefilled Syringes Small Molecules Market Share (%), by key players
    3.6 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Key Insights - Regulatory Approvals-Europe
    3.7 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Key Insights - Regulatory Approvals-U.S.
    3.8 U.S. & EU5 Prefilled Syringes Small Molecules Market –Disease Prevalence
    3.9 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis- List of PFS Small Molecules 
    3.10 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-PFS Small Molecules Marketers 
    3.11 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-PFS Small Molecule CMOs 
    3.12 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Country/Region
    3.13 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By EU5 Countries
    3.14 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Small Molecules Category
    3.15 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Small Molecules Category in U.S.
    3.16 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Small Molecules Category in EU5
    3.17 U.S. & EU5 Prefilled Syringes Small Molecules Market-Pricing Analysis
    3.18 U.S. & EU5 Prefilled Syringes Small Molecules Market Volume Forecast (Mn Units), 2014-2024, By Small Molecules category
    3.19 U.S. & EU5 Prefilled Syringes Small Molecules Market Volume Forecast (Mn Units), 2014-2024, By Small Molecules category in U.S.
    3.20 U.S. & EU5 Prefilled Syringes Small Molecules Market Volume Forecast (Mn Units), 2014-2024, By Small Molecules category in EU5

4 U.S & EU5 Prefilled Syringes Small Molecules Market Company Profiles
    4.1 U.S. & EU5 Prefilled Syringes Small Molecules Market Analysis-Competition Matrix
    4.2 Fresenius Kabi AG 
          4.2.1 Financial Overview
          4.2.2 Product Portfolio
          4.2.3 Business Strategies
          4.2.4 Recent Developments
    4.3 Hospira Inc. (Pfizer’s Subsidiary) 
          4.3.1 Financial Overview
          4.3.2 Product Portfolio
          4.3.3 Business Strategies
          4.3.4 Recent Developments
    4.4 Sanofi 
          4.4.1 Financial Overview
          4.4.2 Product Portfolio
          4.4.3 Business Strategies
          4.4.4 Recent Developments
    4.5 Becton, Dickinson and Company 
          4.5.1 Financial Overview
          4.5.2 Product Portfolio
          4.5.3 Business Strategies
          4.5.4 Recent Developments
    4.6 Teva Pharmaceutical Industries Ltd 
          4.6.1 Financial Overview
          4.6.2 Product Portfolio
          4.6.3 Business Strategies
          4.6.4 Recent Developments
    4.7 Pfizer Inc.
          4.7.1 Financial Overview
          4.7.2 Product Portfolio
          4.7.3 Business Strategies
          4.7.4 Recent Developments
    4.8 Mylan N.V. 
          4.8.1 Financial Overview
          4.8.2 Product Portfolio
          4.8.3 Business Strategies
          4.8.4 Recent Developments

List of Figures

Figure 1 U.S. and EU5 Prefilled Syringes Small Molecules Market by Small Molecule Therapeutic Category 2015.

List of Tables

Table 1 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Country/Region 
Table 2 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By EU5 Countries 
Table 3 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Small Molecules Category
Table 4 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Small Molecules Category in U.S.
Table 5 U.S. & EU5 Prefilled Syringes Small Molecules Market Size Forecast (U.S.$ Mn), 2014-2024, By Small Molecules Category in EU5 
Table 6 U.S. & EU5 Prefilled Syringes Small Molecules Market Volume Forecast (Mn Units), 2014-2024, By Small Molecules category 
Table 7 U.S. & EU5 Prefilled Syringes Small Molecules Market Volume Forecast (Mn Units), 2014-2024, By Small Molecules category in U.S.
Table 8 U.S. & EU5 Prefilled Syringes Small Molecules Market Volume Forecast (Mn Units), 2014-2024, By Small Molecules category in EU5


 
 
Back To Top